Testosterone Cypionate Injection Shortage

• • Depo-Testosterone intramuscular injection, Pfizer, 100 mg/mL, 10 mL vial, NDC 00009-0347-02
  • Depo-Testosterone intramuscular injection, Pfizer, 200 mg/mL, 1 mL vial, 1 count, NDC 00009-0417-01
  • Depo-Testosterone intramuscular injection, Pfizer, 200 mg/mL, 10 mL vial, 1 count, NDC 00009-0417-02
  • Testosterone cypionate intramuscular injection, Eugia US, 200 mg/mL, 10 mL vial, 1 count, NDC 55150-0278-01
  • Testosterone cypionate intramuscular injection, Hikma, 200 mg/mL, 1 mL vial, 1 count, NDC 00143-9659-01
  • Testosterone cypionate intramuscular injection, Hikma, 200 mg/mL, 10 mL vial, 1 count, NDC 00143-9726-01
  • Testosterone cypionate intramuscular injection, Padagis, 200 mg/mL, 1 mL vial, 1 count, NDC 00574-0820-01
  • Testosterone cypionate intramuscular injection, Padagis, 200 mg/mL, 10 mL vial, 1 count, NDC 00574-0820-10
  • Testosterone cypionate intramuscular injection, Pfizer, 100 mg/mL, 10 mL vial, 1 count, NDC 00409-6557-01
  • Testosterone cypionate intramuscular injection, Pfizer, 200 mg/mL, 1 mL vial, 1 count, NDC 00409-6562-01
  • Testosterone cypionate intramuscular injection, Pfizer, 200 mg/mL, 10 mL vial, 1 count, NDC 00409-6562-20
  • Testosterone cypionate intramuscular injection, Sun Pharma, 100 mg/mL, 10 mL vial, 1 count, NDC 62756-0017-40 - discontinued
  • Testosterone cypionate intramuscular injection, Sun Pharma, 200 mg/mL, 1 mL vial, 1 count, NDC 62756-0015-40 - discontinued
  • Testosterone cypionate intramuscular injection, Sun Pharma, 200 mg/mL, 10 mL vial, 1 count, NDC 62756-0016-40 - discontinued

• • Cipla did not provide a reason for the shortage. The 200 mg/mL 10 mL vials were discontinued in 2022.
  • Eugia launched testosterone cypionate in late-2023.
  • Hikma did not provide a reason for the shortage.
  • Padagis did not provide a reason for the shortage. They are focusing on the 1 mL size.
  • Pfizer has testosterone cypionate and Depo-Testosterone on shortage due to increased demand and manufacturing delays.
  • Sun Pharma discontinued testosterone cypionate in late-2023.

• • Testosterone cypionate intramuscular injection, Cipla USA, 200 mg/mL, 1 mL vial, 1 count, NDC 69097-0802-32
  • Testosterone cypionate intramuscular injection, Eugia US, 100 mg/mL, 10 mL vial, 1 count, NDC 55150-0276-01
  • Testosterone cypionate intramuscular injection, Eugia US, 200 mg/mL, 1 mL vial, 1 count, NDC 55150-0277-01

Estimated Resupply Dates

• • Hikma has testosterone cypionate 200 mg/mL 1 mL and 10 mL vials on allocation.
  • Padagis has testosterone cypionate 200 mg/mL 1 mL vials on allocation. The 10 mL vials are on long-term back order and the company cannot estimate a release date.
  • Pfizer has testosterone cypionate 200 mg/mL 1 mL and 10 mL vials and 100 mg/mL 10 mL vials available in limited supply.
  • Pfizer has Depo-Testosterone 200 mg/mL 1 mL and 10 mL vials and 100 mg/mL 10 mL vials on back order and the company estimates a release date of December 2027.